Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development.
There are a few unusual things about the infant botulism outbreak that prompted formula maker ByHeart to recall all of its ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback